Literature DB >> 2325794

Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression.

M Marangella1, M Bruno, D Cosseddu, M Manganaro, A Tricerri, C Vitale, F Linari.   

Abstract

The occurrence of chronic renal insufficiency was investigated in 171 patients with severe idiopathic calcium stone disease. Ninety healthy subjects matched for age and sex were used as controls. The patients were thereafter subclassified into two subgroups, assuming a GFR of 80 ml/min/1.73 m2 body surface area as a cut-off value: the normal GFR, 141 patients, and the impaired GFR, 30 patients. The normal GFR group included more males and the patients were younger both at onset and at presentation. In the impaired GFR group the disease lasted longer, but the overall stones and the stone recurrence rate were as high as those of the normal GFR patients. The single stone episodes were more severe in the former group as suggested by the occurrence of more surgery and complications. The GFR level was in part predicted by the age of patients; however, stone disease was shown to induce a clear-cut influence in accelerating the natural worsening of GFR with age. The onset of renal insufficiency causes multiple changes in renal pathophysiology, which result in a sharp decrease in the urine saturation with respect to calcium salts. These changes account for the decrease in the stone recurrence rate in the impaired GFR group. Thus, unless factors independent of or complicating the calcium stone disease supervene, the renal insufficiency of treated patients remains mild and relently progressive.

Entities:  

Mesh:

Year:  1990        PMID: 2325794     DOI: 10.1159/000185884

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  13 in total

1.  Percutaneous nephrolithotomy in patients with normal versus impaired renal function.

Authors:  Ozgur Yaycioglu; Tulga Egilmez; Umit Gul; Tahsin Turunc; Hakan Ozkardes
Journal:  Urol Res       Date:  2007-02-08

2.  Association of Chronic Kidney Disease Stage with 24-Hour Urine Values Among Patients with Nephrolithiasis.

Authors:  Wilson Sui; Josh K Calvert; Nicholas L Kavoussi; Edward R Gould; Nicole L Miller; Cosmin A Bejan; Ryan S Hsi
Journal:  J Endourol       Date:  2020-07-27       Impact factor: 2.942

3.  Use of drugs for nephrolithiasis.

Authors:  Martino Marangella; Corrado Vitale; Cristiana Bagnis; Michele Petrarulo; Alberto Tricerri
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

4.  Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants.

Authors:  Meng Zhe; Zheng Hang
Journal:  Urolithiasis       Date:  2016-11-11       Impact factor: 3.436

5.  Intravenous aminophylline increases the degree of saturation of urine with calcium phosphate and struvite.

Authors:  A Siwińska; J Głuszek; J Maciejewski; D Musialik
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

Review 6.  Chronic kidney disease in kidney stone formers.

Authors:  Andrew D Rule; Amy E Krambeck; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

7.  Efficacy and outcome of surgical intervention in patients with nephrolithiasis and chronic renal failure.

Authors:  I Singh; N P Gupta; A K Hemal; M Aron; P N Dogra; A Seth
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

8.  Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota.

Authors:  Nathan A Saucier; Mukesh K Sinha; Kelly V Liang; Amy E Krambeck; Amy L Weaver; Eric J Bergstralh; Xujian Li; Andrew D Rule; John C Lieske
Journal:  Am J Kidney Dis       Date:  2009-10-22       Impact factor: 8.860

9.  Kidney stones and the risk for chronic kidney disease.

Authors:  Andrew D Rule; Eric J Bergstralh; L Joseph Melton; Xujian Li; Amy L Weaver; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

10.  Nephrolithiasis-induced end stage renal disease.

Authors:  M Ounissi; T Gargueh; M Mahfoudhi; K Boubaker; H Hedri; R Goucha; E Abderrahim; F Ben Hamida; T Ben Abdallah; F El Younsi; H Ben Maiz; A Kheder
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.